Published in Neurobiol Aging on January 03, 2000
Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J (2004) 1.54
The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line. Mol Neurodegener (2009) 1.16
Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury. Neurobiol Aging (2007) 1.08
Biomarkers in Alzheimer's disease: past, present and future. Biomark Med (2010) 0.93
Manganese superoxide dismutase is dispensable for post-natal development and lactation in the murine mammary gland. Free Radic Res (2012) 0.82
Neuronal and vascular oxidative stress in Alzheimer's disease. Curr Neuropharmacol (2011) 0.79
Allicin inhibits oxidative stress-induced mitochondrial dysfunction and apoptosis by promoting PI3K/AKT and CREB/ERK signaling in osteoblast cells. Exp Ther Med (2016) 0.78
Hyperhomocysteinemia inhibits satellite cell regenerative capacity through p38 alpha/beta MAPK signaling. Am J Physiol Heart Circ Physiol (2015) 0.78
Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity. J Exp Neurosci (2016) 0.77
p38 MAP Kinase Links CAR Activation and Inactivation in the Nucleus via Phosphorylation at Threonine 38. Drug Metab Dispos (2016) 0.76
Chum salmon egg extracts induce upregulation of collagen type I and exert antioxidative effects on human dermal fibroblast cultures. Clin Interv Aging (2016) 0.75
Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors. Metab Brain Dis (2017) 0.75
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 6.12
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell (1997) 2.13
CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem (2001) 2.11
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem (2000) 1.98
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem (2001) 1.90
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry (2011) 1.86
Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med (1999) 1.73
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem (1999) 1.52
Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ (2008) 1.46
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res (2001) 1.30
Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem (2000) 1.26
The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res (1992) 1.17
High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res (1979) 1.16
Biochemical effects of phosphatidylcholine treatment in rats. Biochem Pharmacol (1984) 1.08
Proteolysis of tau by calpain. Biochem Biophys Res Commun (1989) 1.04
Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity (1995) 1.03
Choline accumulates in erythrocytes during lithium therapy. N Engl J Med (1978) 1.03
Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm (Vienna) (1999) 1.00
Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol (1987) 0.97
Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J Neurochem (1991) 0.96
Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol (1989) 0.94
Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys (2001) 0.92
Phosphoinositide signaling in human brain. Prog Neurobiol (1996) 0.92
Muscarinic receptor stimulation increases regulators of G-protein signaling 2 mRNA levels through a protein kinase C-dependent mechanism. J Biol Chem (1999) 0.91
Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol Aging (1996) 0.91
Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol (1986) 0.90
Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience (2010) 0.90
Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience (2012) 0.90
Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes Brain Behav (2013) 0.88
Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J Neurosci (1996) 0.88
Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res (1996) 0.88
Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem J (1998) 0.87
Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun (1999) 0.87
Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport (1999) 0.86
Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling. Biochem J (1999) 0.86
Pertussis toxin-sensitive G protein alpha-subunits: production of monoclonal antibodies and detection of differential increases on differentiation of PC12 and LA-N-5 cells. J Neurochem (1995) 0.86
Metabolic effects of nicotinamide administration in rats. J Nutr (1983) 0.86
Erythrocyte choline concentrations are elevated in manic patients. Proc Natl Acad Sci U S A (1980) 0.86
The interrelationship between selective tau phosphorylation and microtubule association. Brain Res (1998) 0.86
Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett (1995) 0.85
Further evidence for a muscarinic component to the neural vasodilator innervation of cerebral and cranial extracerebral arteries of the cat. Circ Res (1982) 0.85
Aluminum impairs glucose utilization and cholinergic activity in rat brain in vitro. Toxicology (1986) 0.84
Second messengers regulate RGS2 expression which is targeted to the nucleus. Biochim Biophys Acta (2001) 0.84
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine. J Neurochem (1987) 0.84
A mechanism for the accumulation of choline in erythrocytes during treatment with lithium. Commun Psychopharmacol (1980) 0.84
RGS2: regulation of expression and nuclear localization. Biochem Biophys Res Commun (2001) 0.84
Regulation of acetylcholine synthesis: does cytoplasmic acetylcholine control high affinity choline uptake? Science (1976) 0.84
Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo. Brain Res Mol Brain Res (1997) 0.83
G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem (1994) 0.83
Acetylcholine turnover and compartmentation in rat brain synaptosomes. J Neurochem (1981) 0.83
Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells. J Neurochem (1999) 0.83
Phosphorylation of rat brain cytoskeletal proteins is increased after orally administered aluminum. Brain Res (1988) 0.82
Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res (1979) 0.82
Synaptosomal transport and acetylation of choline. Life Sci (1977) 0.82
Comparison of [3H]phosphatidylinositol and [3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem (1997) 0.82
Brain amino acid concentrations in rats killed by decapitation and microwave irradiation. J Neurosci Methods (1990) 0.82
Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience (1995) 0.81
Oral aluminum alters in vitro protein phosphorylation and kinase activities in rat brain. Neurobiol Aging (1990) 0.81
Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices. Mol Pharmacol (1986) 0.81
Modulation of endogenous ADP-ribosylation in rat brain. Brain Res (1992) 0.81
Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats. Brain Res (1995) 0.81
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid. Exp Neurol (1987) 0.81
Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res Mol Brain Res (1999) 0.81
Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Brain Res Mol Brain Res (1995) 0.80
Regulation of acetylcholine synthesis: control of choline transport and acetylation in synaptosomes. J Neurochem (1978) 0.80
Determination of inositol phosphates and other anions in rat brain. J Chromatogr Sci (1989) 0.80
Analysis of the convulsant-potentiating effects of lithium in rats. Exp Neurol (1991) 0.80
Neurochemical consequences of status epilepticus induced in rats by coadministration of lithium and pilocarpine. Exp Neurol (1986) 0.80
Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem (1992) 0.80
Reduced Ca2+ flux in synaptosomes from cats with GM1 gangliosidosis. Brain Res (1987) 0.80
Effect of pretreatment under various cationic conditions on acetylcholine content and choline transport in rat whole brain synaptosomes. J Neurochem (1978) 0.80
Aluminum inhibits the fast phase of voltage-dependent calcium influx into synaptosomes. J Neurochem (1987) 0.79
Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Brain Res Mol Brain Res (1994) 0.79
The utilization of choline and acetyl coenzyme A for the synthesis of acetylcholine. J Neurochem (1980) 0.79
Dietary aluminum selectively decreases MAP-2 in brains of developing and adult rats. Neurotoxicology (1992) 0.79
Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells. Neurobiol Aging (2000) 0.78
Modulation of carbachol-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. Neurochem Res (1987) 0.78
Brain G-protein proteolysis by calpain: enhancement by lithium. Brain Res (1994) 0.78
Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry (1991) 0.78
Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease. J Am Geriatr Soc (1990) 0.78
Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem (1995) 0.78
Src family kinase involvement in muscarinic receptor-induced tyrosine phosphorylation in differentiated SH-SY5Y cells. Neurochem Res (2001) 0.77
Increased metabolism of acetylcholine in brain of cats with Gm1 gangliosidosis. Brain Res (1985) 0.77
Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther (1979) 0.77
Cholinergic processes in blood samples from patients with major psychiatric disorders. Biol Psychiatry (1985) 0.77
Effects of phosphatidylcholine administration to rats on choline in blood and choline and acetylcholine in brain. J Pharmacol Exp Ther (1982) 0.77
Formation of triple-stranded bovine DNA in vitro. Nature (1975) 0.77
Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. Brain Res (2001) 0.77
Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate. Brain Res (1991) 0.77
Free and bound choline blood levels after phosphatidylcholine. Clin Pharmacol Ther (1982) 0.76
Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Brain Res Mol Brain Res (1994) 0.76
Protein synthesis inhibitors attenuate seizures induced in rats by lithium plus pilocarpine. Exp Neurol (1994) 0.76
Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res (1987) 0.76
Increased acetylcholine synthesis and release in brains of cats with GM1 gangliosidosis. J Neurochem (1986) 0.76
Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex. Eur J Pharmacol (1987) 0.76
Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo. Neuroreport (1994) 0.75
Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res (1999) 0.75
Alpha-1 adrenergic receptor binding and adrenergic-stimulated cyclic AMP production in rat cerebral cortex after chronic lithium treatment. J Neural Transm Gen Sect (1990) 0.75
Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl) (1995) 0.75
Inhibition of receptor-coupled phosphoinositide hydrolysis by sulfur-containing amino acids in rat brain slices. Biochem Pharmacol (1989) 0.75